phosphorylcholine has been researched along with Chronic Illness in 20 studies
Phosphorylcholine: Calcium and magnesium salts used therapeutically in hepatobiliary dysfunction.
phosphocholine : The phosphate of choline; and the parent compound of the phosphocholine family.
| Excerpt | Relevance | Reference |
|---|---|---|
| "After 4 weeks of treatment, Urticaria Activity Score (UAS7) levels were substantially more reduced in miltefosine-treated patients (-6." | 9.17 | Randomized, double-blind, placebo-controlled study of safety and efficacy of miltefosine in antihistamine-resistant chronic spontaneous urticaria. ( Bieber, T; Biedermann, T; Brasch, J; Dominicus, R; Hunzelmann, N; Jakob, T; Magerl, M; Mahler, V; Maurer, M; Popp, G; Rother, M; Schäkel, K; Schlingensiepen, R; Schmitt, J; Siebenhaar, F; Simon, JC; Staubach, P; Wedi, B; Weidner, C, 2013) |
| "A prospective randomized double-blind controlled trial in children with recurrent acute otitis media and chronic otitis media with effusion; 240 children were randomized to receive a phosphorylcholine-coated tube in one ear and an uncoated tube in the other." | 9.15 | A randomized double-blind controlled trial of phosphorylcholine-coated tympanostomy tube versus standard tympanostomy tube in children with recurrent acute and chronic otitis media. ( Corsten, G; Hong, P; Johnson, LB; Smith, N, 2011) |
| "After 4 weeks of treatment, Urticaria Activity Score (UAS7) levels were substantially more reduced in miltefosine-treated patients (-6." | 5.17 | Randomized, double-blind, placebo-controlled study of safety and efficacy of miltefosine in antihistamine-resistant chronic spontaneous urticaria. ( Bieber, T; Biedermann, T; Brasch, J; Dominicus, R; Hunzelmann, N; Jakob, T; Magerl, M; Mahler, V; Maurer, M; Popp, G; Rother, M; Schäkel, K; Schlingensiepen, R; Schmitt, J; Siebenhaar, F; Simon, JC; Staubach, P; Wedi, B; Weidner, C, 2013) |
| "A prospective randomized double-blind controlled trial in children with recurrent acute otitis media and chronic otitis media with effusion; 240 children were randomized to receive a phosphorylcholine-coated tube in one ear and an uncoated tube in the other." | 5.15 | A randomized double-blind controlled trial of phosphorylcholine-coated tympanostomy tube versus standard tympanostomy tube in children with recurrent acute and chronic otitis media. ( Corsten, G; Hong, P; Johnson, LB; Smith, N, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (10.00) | 18.7374 |
| 1990's | 9 (45.00) | 18.2507 |
| 2000's | 2 (10.00) | 29.6817 |
| 2010's | 5 (25.00) | 24.3611 |
| 2020's | 2 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dean, DA | 1 |
| Gautham, G | 1 |
| Siqueira-Neto, JL | 1 |
| McKerrow, JH | 1 |
| Dorrestein, PC | 1 |
| McCall, LI | 1 |
| Mano, C | 1 |
| Kongkaew, A | 1 |
| Tippawangkosol, P | 1 |
| Junkum, A | 1 |
| Siriyasatien, P | 1 |
| Jariyapan, N | 1 |
| Zhao, C | 1 |
| Li, Z | 1 |
| Ji, L | 1 |
| Ma, J | 1 |
| Ge, RL | 1 |
| Cui, S | 1 |
| Barrio, S | 1 |
| Gallardo, M | 1 |
| Arenas, A | 1 |
| Ayala, R | 1 |
| Rapado, I | 1 |
| Rueda, D | 1 |
| Jiménez-Ubieto, A | 1 |
| Albizua, E | 1 |
| Burgaleta, C | 1 |
| Gilsanz, F | 1 |
| Martinez-Lopez, J | 1 |
| Hong, P | 1 |
| Smith, N | 1 |
| Johnson, LB | 1 |
| Corsten, G | 1 |
| Magerl, M | 1 |
| Rother, M | 1 |
| Bieber, T | 1 |
| Biedermann, T | 1 |
| Brasch, J | 1 |
| Dominicus, R | 1 |
| Hunzelmann, N | 1 |
| Jakob, T | 1 |
| Mahler, V | 1 |
| Popp, G | 1 |
| Schäkel, K | 1 |
| Schlingensiepen, R | 1 |
| Schmitt, J | 1 |
| Siebenhaar, F | 1 |
| Simon, JC | 1 |
| Staubach, P | 1 |
| Wedi, B | 1 |
| Weidner, C | 1 |
| Maurer, M | 1 |
| Bahadue, FL | 1 |
| Soll, R | 1 |
| Vasseneix, C | 1 |
| Gargala, G | 1 |
| François, A | 1 |
| Hellot, MF | 1 |
| Duclos, C | 1 |
| Muraine, M | 1 |
| Benichou, J | 1 |
| Ballet, JJ | 1 |
| Brasseur, G | 1 |
| Favennec, L | 1 |
| Barbier, M | 1 |
| Oliver, A | 1 |
| Rao, J | 1 |
| Hanna, SL | 1 |
| Goldberg, JB | 1 |
| Albertí, S | 1 |
| Proietti, C | 1 |
| Imperiale, A | 1 |
| Chiti, D | 1 |
| Sell, M | 1 |
| Cotton, R | 1 |
| Hirata, T | 1 |
| Guthrie, R | 1 |
| LeBlanc, M | 1 |
| Mammel, M | 1 |
| Long, W | 2 |
| Sauve, R | 1 |
| Vincer, M | 1 |
| Bard, H | 1 |
| Derleth, D | 1 |
| Stevenson, D | 1 |
| Pauly, T | 1 |
| Robertson, C | 1 |
| Anzueto, A | 1 |
| Jubran, A | 1 |
| Ohar, JA | 1 |
| Piquette, CA | 1 |
| Rennard, SI | 1 |
| Colice, G | 1 |
| Pattishall, EN | 1 |
| Barrett, J | 1 |
| Engle, M | 1 |
| Perret, KA | 1 |
| Rubin, BK | 1 |
| Aramaki, M | 1 |
| Nagasawa, T | 1 |
| Koseki, T | 1 |
| Ishikawa, I | 1 |
| Potwarka, JJ | 1 |
| Drost, DJ | 1 |
| Williamson, PC | 1 |
| Carr, T | 1 |
| Canaran, G | 1 |
| Rylett, WJ | 1 |
| Neufeld, RW | 1 |
| Salvadorini, F | 1 |
| Galeone, F | 1 |
| Marescotti, V | 1 |
| Saba, P | 1 |
| Lal, RB | 1 |
| Dhawan, RR | 1 |
| Ramzy, RM | 1 |
| Farris, RM | 1 |
| Gad, AA | 1 |
| Nightingale, SL | 1 |
| Nishinarita, S | 1 |
| Sawada, S | 1 |
| Horie, T | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Pulse Oximetry With Clinical Observation to Screen for Lung Disease in Neonates[NCT02533583] | 15,000 participants (Anticipated) | Observational | 2015-11-30 | Active, not recruiting | |||
| Lung UltrasouNd Guided Surfactant Therapy in Preterm Infants: an International Multicentric Randomized Control Trial (LUNG Study)[NCT05198375] | 668 participants (Anticipated) | Interventional | 2022-04-05 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for phosphorylcholine and Chronic Illness
| Article | Year |
|---|---|
Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome.
Topics: Acute Disease; Acute Lung Injury; Chronic Disease; Drug Combinations; Fatty Alcohols; Humans; Infant | 2012 |
Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome.
Topics: Acute Disease; Acute Lung Injury; Chronic Disease; Drug Combinations; Fatty Alcohols; Humans; Infant | 2012 |
Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome.
Topics: Acute Disease; Acute Lung Injury; Chronic Disease; Drug Combinations; Fatty Alcohols; Humans; Infant | 2012 |
Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome.
Topics: Acute Disease; Acute Lung Injury; Chronic Disease; Drug Combinations; Fatty Alcohols; Humans; Infant | 2012 |
7 trials available for phosphorylcholine and Chronic Illness
| Article | Year |
|---|---|
A randomized double-blind controlled trial of phosphorylcholine-coated tympanostomy tube versus standard tympanostomy tube in children with recurrent acute and chronic otitis media.
Topics: Acute Disease; Child; Child, Preschool; Chronic Disease; Coated Materials, Biocompatible; Double-Bli | 2011 |
Randomized, double-blind, placebo-controlled study of safety and efficacy of miltefosine in antihistamine-resistant chronic spontaneous urticaria.
Topics: Chronic Disease; Double-Blind Method; Histamine Antagonists; Humans; Phosphorylcholine; Placebos; Ur | 2013 |
One-year follow-up of 273 infants with birth weights of 700 to 1100 grams after prophylactic treatment of respiratory distress syndrome with synthetic surfactant or air placebo. American Exosurf Neonatal Study Group I.
Topics: Air; Child Development; Chronic Disease; Double-Blind Method; Drug Combinations; Fatty Alcohols; Fem | 1995 |
Outcome at 1-year adjusted age of 957 infants weighing more than 1250 grams with respiratory distress syndrome randomized to receive synthetic surfactant or air placebo. American and Canadian Exosurf Neonatal Study Groups.
Topics: Air; Child Development; Chronic Disease; Double-Blind Method; Drug Combinations; Fatty Alcohols; Fem | 1995 |
A multicenter, randomized trial comparing synthetic surfactant with modified bovine surfactant extract in the treatment of neonatal respiratory distress syndrome. Vermont-Oxford Neonatal Network.
Topics: Biological Products; Chronic Disease; Drug Combinations; Fatty Alcohols; Female; Humans; Infant, Low | 1996 |
Effects of aerosolized surfactant in patients with stable chronic bronchitis: a prospective randomized controlled trial.
Topics: Administration, Intranasal; Aerosols; Aged; Bronchitis; Chronic Disease; Double-Blind Method; Drug C | 1997 |
A 1H-decoupled 31P chemical shift imaging study of medicated schizophrenic patients and healthy controls.
Topics: Adult; Antipsychotic Agents; Cerebral Cortex; Chlorpromazine; Chronic Disease; Female; Humans; Magne | 1999 |
12 other studies available for phosphorylcholine and Chronic Illness
| Article | Year |
|---|---|
Spatial metabolomics identifies localized chemical changes in heart tissue during chronic cardiac Chagas Disease.
Topics: Animals; Carnitine; Chagas Cardiomyopathy; Chronic Disease; Heart; Humans; Male; Metabolomics; Mice; | 2021 |
In vitro susceptibility to miltefosine of amphotericin B-resistant Leishmania (Mundinia) martiniquensis.
Topics: Amphotericin B; Antiprotozoal Agents; Chronic Disease; Humans; Leishmania; Leishmaniasis; Leishmania | 2023 |
PI3K-Akt Signal Transduction Molecules Maybe Involved in Downregulation of Erythroblasts Apoptosis and Perifosine Increased Its Apoptosis in Chronic Mountain Sickness.
Topics: Adult; Altitude Sickness; Apoptosis; bcl-X Protein; Bone Marrow Cells; Caspase 9; Celecoxib; China; | 2017 |
Inhibition of related JAK/STAT pathways with molecular targeted drugs shows strong synergy with ruxolitinib in chronic myeloproliferative neoplasm.
Topics: Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Cell Proliferation; Cells, Cultured; Chronic D | 2013 |
A keratitis rat model for evaluation of anti-Acanthamoeba polyphaga agents.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Administration, Topical; Animals; Antiprotozoal Agents; Benzam | 2006 |
Novel phosphorylcholine-containing protein of Pseudomonas aeruginosa chronic infection isolates interacts with airway epithelial cells.
Topics: Acute Disease; Animals; Bacterial Proteins; Chronic Disease; Disease Models, Animal; Humans; Mice; M | 2008 |
[Treatment of chronic hepatopathies with phosphorylcholine and pantethine].
Topics: Adult; Aged; Choline; Chronic Disease; Drug Combinations; Female; Humans; Liver Diseases; Male; Midd | 1984 |
Presence of activated B-1 cells in chronic inflamed gingival tissue.
Topics: Adult; Antibodies, Bacterial; B-Lymphocyte Subsets; Chronic Disease; DNA, Single-Stranded; Escherich | 1998 |
[Effect of CDP-choline on GH release in patients with chronic psychopathy].
Topics: Adult; Choline; Chronic Disease; Depression; Female; Growth Hormone; Humans; Male; Mental Disorders; | 1978 |
C-reactive protein in patients with lymphatic filariasis: increased expression on lymphocytes in chronic lymphatic obstruction.
Topics: Adolescent; Adult; Aged; Animals; Antigens, Helminth; Binding, Competitive; C-Reactive Protein; Chro | 1991 |
From the Food and Drug Administration.
Topics: Chronic Disease; Diet Fads; Dietary Fiber; Drug Combinations; Esophageal Stenosis; Fatty Alcohols; F | 1990 |
Phosphorylcholine antibodies in pulmonary infection.
Topics: Acute Disease; Adult; Aged; Animals; Antibody Specificity; B-Lymphocytes; Bronchitis; Bronchopneumon | 1990 |